N

NextCure
D

NXTC

0.72990
USD
-0.01
(-1.36%)
Market Closed
Volume
10
EPS
-1
Div Yield
-
P/E
-0
Market Cap
20,442,079
OverviewSignalsIdeasNews
Related Instruments
    CHKP
    CHKP
    -2.170
    (-0.99%)
    216.890 USD
    CRWD
    CRWD
    -29.49
    (-6.76%)
    406.64 USD
    F
    FFIV
    -9.10
    (-2.99%)
    295.56 USD
    FTNT
    FTNT
    -4.165
    (-3.65%)
    110.035 USD
    PANW
    PANW
    -7.720
    (-3.88%)
    191.080 USD
    Q
    QLYS
    -3.250
    (-2.33%)
    136.160 USD
    V
    VRNT
    -0.970
    (-3.84%)
    24.310 USD
    ZS
    ZS
    -8.490
    (-4.10%)
    198.540 USD
    More
News

Title: NextCure

Sector: Healthcare
Industry: Biotechnology
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.